시장보고서
상품코드
1732851

방사선 치료 시장 - 산업규모, 점유율, 동향, 기회, 예측, 유형별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

Radiotherapy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Type, By Application, By End-User, By Region and Competition, 2020-2030F

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 183 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

방사선 치료 세계 시장은 2024년에 65억 4,000만 달러로 평가되었고, 2030년에는 106억 8,000만 달러에 이를 것으로 예측되고, 예측 기간 중 CAGR은 8.52%를 나타낼 전망입니다.

방사선 치료는 전리방사선을 이용하여 암세포를 제거 또는 축소하고 질병의 진행을 관리하는 암치료의 요점으로 계속 되고 있습니다. 적은 부작용을 제공하고 치료의 전망을 바꾸고 있습니다. 또한, AI, 실시간 이미징, 방사선 수술 기술의 통합은 치료 결과와 업무 효율을 높이고 있습니다.

시장 개요
예측 기간 2026-2030년
시장 규모 : 2024년 65억 4,000만 달러
시장 규모 : 2030년 106억 8,000만 달러
CAGR : 2025-2030년 8.52%
급성장 부문 병원
최대 시장 북미

시장 성장 촉진요인

기술 진보

주요 시장 과제

비용과 접근성 장벽

주요 시장 동향

고급 방사선 조사 기술

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계 방사선 치료 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율 및 예측
    • 유형별(외 조사 요법, 내 조사 요법, 전신 방사선 요법)
    • 용도별(피부암 및 입술암, 유방암, 전립선암, 자궁경부암, 폐암, 기타)
    • 최종 사용자별(병원, 조사 기관, 외래, 방사선 치료 센터)
    • 지역별
    • 기업별(2024년)
  • 시장 맵

제6장 북미의 방사선 치료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율·예측
  • 북미 : 국가별 분석
    • 미국
    • 캐나다
    • 멕시코

제7장 유럽의 방사선 치료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율 및 예측
  • 유럽 : 국가별 분석
    • 독일
    • 영국
    • 이탈리아
    • 프랑스
    • 스페인

제8장 아시아태평양의 방사선 치료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율 및 예측
  • 아시아태평양 : 국가별 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주

제9장 남미의 방사선 치료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제10장 중동 및 아프리카의 방사선 치료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율 및 예측
  • 중동 및 아프리카 : 국가별 분석
    • 남아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)

제11장 시장 역학

  • 성장 촉진요인
  • 과제

제12장 시장 동향과 발전

  • 최근 동향
  • 제품 출시
  • 합병과 인수

제13장 세계 방사선 치료 시장 : SWOT 분석

제14장 경쟁 구도

  • Canon Medical Systems Corporation
  • GE Healthcare
  • Elekta
  • ViewRay Technologies, Inc.
  • Mevion Medical Systems
  • Eckert & Ziegler(BEBIG Medical)
  • Siemens Healthineers AG
  • Accuray Incorporated
  • Isoray Inc.
  • Hitachi, Ltd.
  • ALCEN(PMB)

제15장 전략적 제안

제16장 기업 소개와 면책사항

SHW 25.06.04

The Global Radiotherapy Market was valued at USD 6.54 Billion in 2024 and is projected to reach USD 10.68 Billion by 2030, expanding at a CAGR of 8.52% during the forecast period. Radiotherapy remains a cornerstone in cancer treatment, employing ionizing radiation to eliminate or shrink cancer cells and manage disease progression. With the increasing global incidence of cancer and the rising focus on non-invasive therapeutic solutions, radiotherapy is witnessing robust growth. The adoption of advanced technologies like IMRT, SBRT, and proton therapy is transforming the treatment landscape, offering higher precision and fewer side effects. Additionally, the integration of AI, real-time imaging, and radiosurgery techniques is enhancing treatment outcomes and operational efficiency. The global healthcare ecosystem's emphasis on effective oncology care, coupled with the growing demand for personalized and targeted treatments, continues to drive the expansion of the radiotherapy market.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 6.54 Billion
Market Size 2030USD 10.68 Billion
CAGR 2025-20308.52%
Fastest Growing SegmentHospitals
Largest MarketNorth America

Key Market Drivers

Technological Advancements

Ongoing technological innovations have significantly fueled the growth of the Global Radiotherapy Market. The emergence of advanced techniques like Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Body Radiation Therapy (SBRT), and Proton Therapy has revolutionized cancer care by enabling highly accurate targeting of tumors while preserving surrounding healthy tissue. This precision leads to improved outcomes and fewer adverse effects, making radiotherapy a preferred choice. Artificial Intelligence (AI) and Machine Learning (ML) are increasingly integrated into treatment planning, enhancing dose optimization and patient response prediction. Image-Guided Radiotherapy (IGRT) further ensures real-time monitoring during treatment, improving targeting accuracy. Additionally, the development of Radiosurgery and Stereotactic Radiosurgery (SRS) allows for high-dose, single-session treatments for small tumors, offering patients convenience and reduced treatment durations.

Key Market Challenges

Cost and Accessibility Barriers

One of the major barriers in the radiotherapy market is the high cost of implementation. Advanced radiotherapy systems, such as linear accelerators and proton therapy units, demand substantial capital investment, which can be a major hurdle for healthcare providers, especially in under-resourced regions. Beyond the purchase, ongoing maintenance, staff training, and operational expenses place additional financial pressure on facilities. Disparities in access are also a concern, with rural and low-income areas often lacking sufficient infrastructure for radiotherapy services. These challenges contribute to unequal access to advanced cancer care, limiting the market's reach and slowing the pace of widespread adoption despite growing demand.

Key Market Trends

Advanced Radiation Delivery Techniques

The evolution of advanced radiation delivery methods is reshaping the radiotherapy landscape. Techniques such as IMRT allow for modulation of radiation intensity to different areas of the tumor, minimizing impact on nearby healthy tissues and improving treatment precision. Proton therapy offers an even more targeted approach, as protons release energy directly at the tumor site, reducing collateral damage. Additionally, hypofractionation-delivering higher doses over fewer sessions-is gaining popularity for its convenience and efficiency. Stereotactic Radiosurgery (SRS), a form of hypofractionation, is increasingly used for treating small brain and body tumors. These innovations align with the growing demand for personalized treatment strategies that prioritize both efficacy and patient quality of life.

Key Market Players

  • Canon Medical Systems Corporation
  • GE Healthcare
  • Elekta
  • ViewRay Technologies, Inc.
  • Mevion Medical Systems
  • Eckert & Ziegler (BEBIG Medical)
  • Siemens Healthineers AG
  • Accuray Incorporated
  • Isoray Inc.
  • Hitachi, Ltd.
  • ALCEN (PMB)

Report Scope:

In this report, the Global Radiotherapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Radiotherapy Market, By Type:

  • External Beam Radiation Therapy
  • Internal Radiation Therapy
  • Systemic Radiation Therapy

Radiotherapy Market, By Application:

  • Skin & Lip Cancer
  • Breast Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Lung Cancer
  • Others

Radiotherapy Market, By End-User:

  • Hospitals
  • Research Institutes
  • Ambulatory and Radiotherapy Centers

Radiotherapy Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Radiotherapy Market.

Available Customizations:

Global Radiotherapy market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Radiotherapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (External Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiation Therapy)
    • 5.2.2. By Application (Skin & Lip Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer, Others)
    • 5.2.3. By End-User (Hospitals, Research Institutes, Ambulatory and Radiotherapy Centers)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Radiotherapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By End-User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Radiotherapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End-User
    • 6.3.2. Canada Radiotherapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End-User
    • 6.3.3. Mexico Radiotherapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End-User

7. Europe Radiotherapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By End-User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Radiotherapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End-User
    • 7.3.2. United Kingdom Radiotherapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End-User
    • 7.3.3. Italy Radiotherapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End-User
    • 7.3.4. France Radiotherapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End-User
    • 7.3.5. Spain Radiotherapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End-User

8. Asia-Pacific Radiotherapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Radiotherapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End-User
    • 8.3.2. India Radiotherapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End-User
    • 8.3.3. Japan Radiotherapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End-User
    • 8.3.4. South Korea Radiotherapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End-User
    • 8.3.5. Australia Radiotherapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End-User

9. South America Radiotherapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End-User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Radiotherapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End-User
    • 9.3.2. Argentina Radiotherapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End-User
    • 9.3.3. Colombia Radiotherapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End-User

10. Middle East and Africa Radiotherapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By End-User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Radiotherapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End-User
    • 10.3.2. Saudi Arabia Radiotherapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End-User
    • 10.3.3. UAE Radiotherapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Radiotherapy Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Canon Medical Systems Corporation
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. GE Healthcare
  • 14.3. Elekta
  • 14.4. ViewRay Technologies, Inc.
  • 14.5. Mevion Medical Systems
  • 14.6. Eckert & Ziegler (BEBIG Medical)
  • 14.7. Siemens Healthineers AG
  • 14.8. Accuray Incorporated
  • 14.9. Isoray Inc.
  • 14.10. Hitachi, Ltd.
  • 14.11. ALCEN (PMB)

15. Strategic Recommendations

16. About Us & Disclaimer

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제